Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Intrinsic Value
Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, and operational results services. [ Read More ]
The intrinsic value of one
MDRX
stock under the Base Case scenario is
11.1
USD.
Compared to the current market price of 7.55 USD,
Allscripts Healthcare Solutions Inc
is
Undervalued by 32%.
Allscripts Healthcare Solutions Inc's market capitalization is 825.2m USD.
MDRX stock price is 7.55 USD.
MDRX stock price (7.55 USD) is 32% less than its Intrinsic Value (11.1 USD).
MDRX has upside potential of 97% compared to the average analyst price target.
Open Wall St Estimates
MDRX's ROE (Return on Equity) for the past 12 months is very low and is equal to 5%.
MDRX's Revenue has grown by an exceptional 20% over the past 12 months.
MDRX's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
MDRX's ROIC (Return on Invested Capital) has increased in the last 3 years from -5% to 4%.
MDRX has positive three-year average ROE (Return on Equity): 17%. The company is efficient at transforming stockholders' equity into net income.
MDRX has positive Net Income for the last twelve months.
MDRX has positive Operating Income for the last twelve months.
MDRX's ROE (Return on Equity) has significantly decreased in the last 3 years from 50% to 5%.
MDRX has positive Gross Profit for the last twelve months.
MDRX has negative three-year average ROIC (Return on Invested Capital): -1%. The company is not efficient at using invested capital to generate operating income.
MDRX's Altman Z-Score is very high and is equal to 3.24.
MDRX's Revenue is forecast to fall at a rate of 23% per year over the next 3 years.
MDRX has negative Net Debt. This means that the company has more cash and short-term investments (493m USD) than debt (200m USD).
MDRX has positive Free Cash Flow for the last twelve months.
MDRX's short-term assets (811m USD) exceed its short-term liabilties (253m USD).
MDRX's long-term assets (2B USD) exceed its long-term liabilties (514m USD).
MDRX's D/E (Debt to Equity) is very low and is equal to 0.17.
Valuation Backtest
Allscripts Healthcare Solutions Inc
Run backtest to discover the historical profit from buying and selling
MDRX
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Allscripts Healthcare Solutions Inc
Balance Sheet Decomposition
Allscripts Healthcare Solutions Inc
| Current Assets | 810.8m |
| Cash & Short-Term Investments | 492.6m |
| Receivables | 234.5m |
| Other Current Assets | 83.7m |
| Non-Current Assets | 879.9m |
| Long-Term Investments | 12.1m |
| PP&E | 26.2m |
| Intangibles | 747.3m |
| Other Non-Current Assets | 94.3m |
| Current Liabilities | 253.1m |
| Accounts Payable | 12.6m |
| Accrued Liabilities | 122.9m |
| Other Current Liabilities | 117.6m |
| Non-Current Liabilities | 260.5m |
| Long-Term Debt | 200.3m |
| Other Non-Current Liabilities | 60.2m |
Earnings Waterfall
Allscripts Healthcare Solutions Inc
|
Revenue
|
837.2m
USD
|
|
Cost of Revenue
|
-431.8m
USD
|
|
Gross Profit
|
405.4m
USD
|
|
Operating Expenses
|
-337.6m
USD
|
|
Operating Income
|
67.8m
USD
|
|
Other Expenses
|
-7.1m
USD
|
|
Net Income
|
60.7m
USD
|
Free Cash Flow Analysis
Allscripts Healthcare Solutions Inc
What is Free Cash Flow?
MDRX Profitability Score
Profitability Due Diligence
Allscripts Healthcare Solutions Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Allscripts Healthcare Solutions Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
MDRX Solvency Score
Solvency Due Diligence
Allscripts Healthcare Solutions Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Allscripts Healthcare Solutions Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDRX Price Targets Summary
Allscripts Healthcare Solutions Inc
According to Wall Street analysts, the average 1-year price target for
MDRX
is 14.89 USD
with a low forecast of 8.08 USD and a high forecast of 27.3 USD.
Ownership
MDRX Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
MDRX Price
Allscripts Healthcare Solutions Inc
| Average Annual Return | 18.23% |
| Standard Deviation of Annual Returns | 25.28% |
| Max Drawdown | -74% |
| Market Capitalization | 825.2m USD |
| Shares Outstanding | 108 400 000 |
| Percentage of Shares Shorted | 14.91% |
Company Profile
Allscripts Healthcare Solutions Inc
Country
Industry
Market Cap
Dividend Yield
Description
Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, and operational results services. The company is headquartered in Chicago, Illinois and currently employs 8,000 full-time employees. The Company’s segments include the Hospitals and Large Physician Practices and the Veradigm. The Hospitals and Large Physician Practices reportable segment offers integrated clinical and financial management solutions, which primarily include (electronic health record) EHR-related software, related installation, support and maintenance, outsourcing and private cloud hosting. The Veradigm reportable segment offers payer and life sciences solutions, which are mainly targeted at payers, life sciences companies and other key healthcare stakeholders. The Veradigm also offers software applications for patient engagement and the sale of EHR software to single-specialty and small and mid-sized physician practices, including related clinical, financial, administrative and operational solutions.
Contact
IPO
Employees
Officers
The intrinsic value of one
MDRX
stock under the Base Case scenario is
11.1
USD.
Compared to the current market price of 7.55 USD,
Allscripts Healthcare Solutions Inc
is
Undervalued by 32%.
You don't have any saved screeners yet
